RaySearch Laboratories AB (publ) (FRA:27R)

Market Cap	1.05B
Revenue (ttm)	116.74M
Net Income (ttm)	20.61M
Shares Out	n/a
EPS (ttm)	0.61
PE Ratio	50.83
Forward PE	n/a
Dividend	0.17 (0.79%)
Ex-Dividend Date	May 23, 2025

Volume	n/a
Average Volume	6
Open	28.00
Previous Close	28.25
Day's Range	28.00 - 28.00
52-Week Range	10.52 - 28.60
Beta	n/a
RSI	74.64
Earnings Date	May 9, 2025

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation...

• Industry: Prepackaged Software
• Founded: 2000
• Employees: 416
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 27R

Financial Performance

In 2024, RaySearch Laboratories AB's revenue was 1.19 billion, an increase of 16.62% compared to the previous year's 1.02 billion. Earnings were 203.51 million, an increase of 149.49%.

Financial numbers in SEK